In some cancers, the ANGPTL4 expression promoted venous invasion and cancer progression in breast cancer, thyroid cancer, colorectal cancer and gastric cancer [68–71], and was associated with a poor prognosis in breast cancer [68]. Here, ANGPTL4 is linked to gastric cancer.